In the present study, we showed that anti-EGFR sensitization of ovarian cancer cells enhanced antibody-dependent cellular cytotoxicity (ADCC) of co-incubated NK cells in the presence of cetuximab, which was correlated with increased tumor cell lysis. This evidence concerns the gene EGFR and ovarian cancer.